With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The underbelly of biopharma, as well as some of its most cutting-edge advances took center stage this week. That’s the topic for this week’s MedHeads, MedCityNews.com’s look at the business of innovation in medicine.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
We’ll explore the aftermath of Martin Shkreli, Turing Pharmaceuticals and the practice of up-pricing drugs. Plus, we’ll discuss the revelations of precision medicine, including Human Longevity CEO J. Craig Venter’s announcement of low-cost exome testing and his feelings on genomics in the public domain.
Join MedCity News reporter Meghana Keshavan, Vice President of Healthcare for Breaking Media Chris Seper, plus special guests John Carroll from FierceBiotech and Luke Timmerman from the Timmerman Report for a conversation on this strange, fascinating week in biopharma.
MedHeads starts at 4 p.m. EDT on Friday, as it does every week. Join us via the YouTube embed below, or on our Google Hangout On Air page.
